Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial
Titel:
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial
Auteur:
Taïeb, Julien André, Thierry El Hajbi, Farid Barbier, Emilie Toullec, Clémence Kim, Stefano Bouche, Olivier Di Fiore, Frederic Chauvenet, Marion Perrier, Hervé Evesque, Ludovic Laurent-Puig, Pierre Emile, Jean-François Bez, Jérémie Lepage, Côme Tougeron, David